3 exciting small cap ASX shares that ought to be on your watchlist

Here's why I would put Audinate Group Limited (ASX:AD8) and these ASX small cap shares on my watchlist…

| More on:
Young male investor smiling looking at laptop as the share price of ASX ETF CRYP goes higher today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to invest in the small side of the Australian share market, I think the three small caps listed below could be worth a closer look.

While there is certainly still a lot of work to be done, they all appear to be carving out bright futures for themselves.

Here's why I think they should be on your watchlist right now:

Audinate Group Limited (ASX: AD8)

Audinate is a digital audio-visual networking technologies provider. It is best known for its innovative Dante audio over IP networking solution which is used widely across the professional live sound, commercial installation, and recording industries globally. This product is the clear market leader with a significant advantage over the competition. And while the pandemic has hit its sales greatly this year, I'm confident this is just a short term headwind and expect demand to increase materially once trading conditions improve.

Serko Ltd (ASX: SKO)

Another small cap share that has been hit by the pandemic is Serko. It is the online travel booking and expense management provider behind the Zeno Travel and Zeno Expense platforms. Zeno Travel provides AI-powered end-to-end travel itineraries, cost control and travel policy compliance to corporate customers. Zeno Expense allows its users to automate and streamline the expense administration function, identify out-of-policy expense claims, and prevent fraud. As with Audinate, I believe demand will bounce back strongly when the pandemic passes and travel markets return to normal.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a healthcare technology company that uses artificial intelligence to assist with the early detection of breast cancer. It achieves this by analysing mammograms and associated patient data. Users can then use this software to provide clinical decision support and practice management tools in a cost-effective way. Volpara is currently generating NZ$19.9 million in annual recurring revenues (ARR), but estimates that it has a US$750 million ARR opportunity in breast cancer screening.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of AUDINATEGL FPO, Serko Ltd, and VOLPARA FPO NZ. The Motley Fool Australia has recommended AUDINATEGL FPO, Serko Ltd, and VOLPARA FPO NZ. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Speculative

Speculative

Bell Potter says this speculative ASX stock can rocket 40%

If you have a high tolerance for risk, then it could be worth checking out Vitrafy Life Sciences Ltd (ASX:…

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Speculative

Why this speculative ASX stock could rise ~50%

Bell Potter sees potential for big returns over the next 12 months.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Speculative

These speculative ASX mining stocks could rise 85%+

Bell Potter has put speculative buy ratings on these stocks this morning.

Read more »

surprised asx investor appearing incredulous at hearing asx share price
Speculative

'Blockbuster opportunity': This speculative ASX stock could rise 70%

Bell Potter thinks exciting times could be around the corner for this buy-rated high risk stock.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

Buy this small cap ASX stock with a 'lucrative opportunity'

Bell Potter thinks this speculative stock could have major upside thanks to its US market opportunity.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Speculative

Broker says this speculative ASX stock could rise over 200%

This high risk option could have major upside according to analysts.

Read more »

Vanadium Resources share price person riding rocket indicating share price increase
Speculative

Meet the speculative ASX stock tipped to rise 180%

Bell Potter thinks this share could almost triple in value.

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
AI Stocks

Brainchip share price tumbles 40% in the past year. What's next?

Brainchip shares have had a topsy-turvy year. So, what’s next for this speculative ASX AI technology stock?

Read more »